Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Brief communication: β-cell function influences dopamine receptor availability.

Dunn JP, Abumrad NN, Patterson BW, Kessler RM, Tamboli RA.

PLoS One. 2019 Mar 8;14(3):e0212738. doi: 10.1371/journal.pone.0212738. eCollection 2019.

2.

Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET.

Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR, Zald DH.

Psychopharmacology (Berl). 2019 Feb;236(2):581-590. doi: 10.1007/s00213-018-5083-5. Epub 2018 Oct 22.

PMID:
30350220
3.

[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.

Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO.

Neuroimage Clin. 2018 Feb 10;18:433-442. doi: 10.1016/j.nicl.2018.02.010. eCollection 2018.

4.

Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.

Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH, Claassen DO.

J Neurosci. 2018 Mar 28;38(13):3230-3239. doi: 10.1523/JNEUROSCI.3082-17.2018. Epub 2018 Feb 26.

5.

Caloric Restriction-Induced Decreases in Dopamine Receptor Availability are Associated with Leptin Concentration.

Dunn JP, Abumrad NN, Kessler RM, Patterson BW, Li R, Marks-Shulman P, Tamboli RA.

Obesity (Silver Spring). 2017 Nov;25(11):1910-1915. doi: 10.1002/oby.22023. Epub 2017 Sep 25.

6.

Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.

Claassen DO, Stark AJ, Spears CA, Petersen KJ, van Wouwe NC, Kessler RM, Zald DH, Donahue MJ.

Mov Disord. 2017 Nov;32(11):1574-1583. doi: 10.1002/mds.27047. Epub 2017 Jun 19.

7.

The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.

Smith CT, Dang LC, Buckholtz JW, Tetreault AM, Cowan RL, Kessler RM, Zald DH.

Transl Psychiatry. 2017 Apr 11;7(4):e1091. doi: 10.1038/tp.2017.45.

8.

Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.

Smith CT, Dang LC, Cowan RL, Kessler RM, Zald DH.

Neuropharmacology. 2016 Sep;108:394-402. doi: 10.1016/j.neuropharm.2016.05.004. Epub 2016 May 10.

9.

Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Smith CT, Weafer J, Cowan RL, Kessler RM, Palmer AA, de Wit H, Zald DH.

J Psychopharmacol. 2016 Apr;30(4):330-43. doi: 10.1177/0269881116631650. Epub 2016 Feb 15.

10.

The neurobiological basis of binge-eating disorder.

Kessler RM, Hutson PH, Herman BK, Potenza MN.

Neurosci Biobehav Rev. 2016 Apr;63:223-38. doi: 10.1016/j.neubiorev.2016.01.013. Epub 2016 Feb 2. Review.

11.

Caudate asymmetry is related to attentional impulsivity and an objective measure of ADHD-like attentional problems in healthy adults.

Dang LC, Samanez-Larkin GR, Young JS, Cowan RL, Kessler RM, Zald DH.

Brain Struct Funct. 2016 Jan;221(1):277-86. doi: 10.1007/s00429-014-0906-6. Epub 2014 Oct 1.

12.

Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.

Rook JM, Tantawy MN, Ansari MS, Felts AS, Stauffer SR, Emmitte KA, Kessler RM, Niswender CM, Daniels JS, Jones CK, Lindsley CW, Conn PJ.

Neuropsychopharmacology. 2015 Feb;40(3):755-65. doi: 10.1038/npp.2014.245. Epub 2014 Sep 22.

13.

Radiation Dosimetry of (18)F-FPEB in Humans.

Kessler RM, Seibyl J, Cowan RL, Zald D, Young JS, Ansari MS, Stabin MG.

J Nucl Med. 2014 Jul;55(7):1119-21. doi: 10.2967/jnumed.113.133843. Epub 2014 May 5.

14.

Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity.

Kessler RM, Zald DH, Ansari MS, Li R, Cowan RL.

Synapse. 2014 Jul;68(7):317-20. doi: 10.1002/syn.21738. Epub 2014 Mar 17. No abstract available.

PMID:
24573975
15.

Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity.

Savage SW, Zald DH, Cowan RL, Volkow ND, Marks-Shulman PA, Kessler RM, Abumrad NN, Dunn JP.

Obesity (Silver Spring). 2014 Jun;22(6):1452-7. doi: 10.1002/oby.20690. Epub 2014 Feb 11.

16.

A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility.

Samanez-Larkin GR, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Arrington CM, Baldwin RM, Smith CE, Treadway MT, Kessler RM, Zald DH.

Biol Psychiatry. 2013 Jul 15;74(2):99-105. doi: 10.1016/j.biopsych.2012.10.032. Epub 2012 Dec 27.

17.

Dopaminergic mechanisms of individual differences in human effort-based decision-making.

Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH.

J Neurosci. 2012 May 2;32(18):6170-6. doi: 10.1523/JNEUROSCI.6459-11.2012.

18.

Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity.

Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW, Ansari MS, Li R, Marks-Shulman P, Abumrad NN.

Diabetes Care. 2012 May;35(5):1105-11. doi: 10.2337/dc11-2250. Epub 2012 Mar 19.

19.

Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.

20.

Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot.

Tantawy MN, Peterson TE, Jones CK, Johnson K, Rook JM, Conn PJ, Baldwin RM, Ansari MS, Kessler RM.

Synapse. 2011 Nov;65(11):1173-80. doi: 10.1002/syn.20955. Epub 2011 Jun 17.

21.

Time series fMRI measures detect changes in pontine raphé following acute tryptophan depletion.

Salomon RM, Cowan RL, Rogers BP, Dietrich MS, Bauernfeind AL, Kessler RM, Gore JC.

Psychiatry Res. 2011 Feb 28;191(2):112-21. doi: 10.1016/j.pscychresns.2010.10.007. Epub 2011 Jan 13.

22.

Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions.

Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, Li R, Doop M, Kessler RM, Zald DH.

Am J Psychiatry. 2011 Apr;168(4):418-26. doi: 10.1176/appi.ajp.2010.10020165. Epub 2010 Dec 15.

23.

Dopaminergic network differences in human impulsivity.

Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH.

Science. 2010 Jul 30;329(5991):532. doi: 10.1126/science.1185778.

24.

Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings.

Dunn JP, Cowan RL, Volkow ND, Feurer ID, Li R, Williams DB, Kessler RM, Abumrad NN.

Brain Res. 2010 Sep 2;1350:123-30. doi: 10.1016/j.brainres.2010.03.064. Epub 2010 Mar 31.

25.

Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits.

Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Cole D, Kessler RM, Zald DH.

Nat Neurosci. 2010 Apr;13(4):419-21. doi: 10.1038/nn.2510. Epub 2010 Mar 14.

26.

The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.

Zald DH, Woodward ND, Cowan RL, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Smith CE, Hakyemez H, Li R, Kessler RM.

Neuroimage. 2010 May 15;51(1):53-62. doi: 10.1016/j.neuroimage.2010.02.006. Epub 2010 Feb 10.

27.

[(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.

Tantawy MN, Jones CK, Baldwin RM, Ansari MS, Conn PJ, Kessler RM, Peterson TE.

Nucl Med Biol. 2009 Nov;36(8):931-40. doi: 10.1016/j.nucmedbio.2009.06.007. Epub 2009 Oct 3.

28.

Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM.

Neuroimage. 2009 May 15;46(1):31-8. doi: 10.1016/j.neuroimage.2009.01.049. Epub 2009 Feb 5. Erratum in: Neuroimage. 2009 Oct 1;47(4):2090.

29.

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

Kessler RM, Woodward ND, Riccardi P, Li R, Ansari MS, Anderson S, Dawant B, Zald D, Meltzer HY.

Biol Psychiatry. 2009 Jun 15;65(12):1024-31. doi: 10.1016/j.biopsych.2008.12.029. Epub 2009 Feb 28.

30.

Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans.

Zald DH, Cowan RL, Riccardi P, Baldwin RM, Ansari MS, Li R, Shelby ES, Smith CE, McHugo M, Kessler RM.

J Neurosci. 2008 Dec 31;28(53):14372-8. doi: 10.1523/JNEUROSCI.2423-08.2008.

31.

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

Jones CK, Brady AE, Davis AA, Xiang Z, Bubser M, Tantawy MN, Kane AS, Bridges TM, Kennedy JP, Bradley SR, Peterson TE, Ansari MS, Baldwin RM, Kessler RM, Deutch AY, Lah JJ, Levey AI, Lindsley CW, Conn PJ.

J Neurosci. 2008 Oct 8;28(41):10422-33. doi: 10.1523/JNEUROSCI.1850-08.2008.

32.

Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?

Kessler RM.

Am J Psychiatry. 2007 Sep;164(9):1310-2. No abstract available.

PMID:
17728411
33.

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.

Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.

Neuropsychopharmacology. 2006 Sep;31(9):1991-2001. Epub 2006 May 31.

34.

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.

Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.

Neuropsychopharmacology. 2005 Dec;30(12):2283-9.

35.

Weigh the risks before limiting coverage.

Kessler RM, Eckstein B.

AHIP Cover. 2005 Mar-Apr;46(2):44. No abstract available.

PMID:
15856802
36.

Obesity: health insurance plans respond to a public health challenge.

Kessler RM, Eckstein B.

AHIP Cover. 2005 Mar-Apr;46(2):38-40, 42. No abstract available.

PMID:
15856801
37.

Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies.

Rieck RW, Ansari MS, Whetsell WO Jr, Deutch AY, Kessler RM.

Neuropsychopharmacology. 2004 Feb;29(2):362-72.

38.

Imaging methods for evaluating brain function in man.

Kessler RM.

Neurobiol Aging. 2003 May-Jun;24 Suppl 1:S21-35; discussion S37-9. Review.

PMID:
12829104
39.

No increased herniation of the cerebellar tonsils in a group of patients with orthostatic intolerance.

Garland EM, Anderson JC, Black BK, Kessler RM, Konrad PE, Robertson D.

Clin Auton Res. 2002 Dec;12(6):472-6.

PMID:
12598952
40.

Regional selectivity in clozapine treatment?

Kessler RM, Meltzer HY.

Am J Psychiatry. 2002 Jun;159(6):1064-5. No abstract available.

PMID:
12042207
41.

Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child.

Osorio A, Kessler RM, Guruprasad H, Isaacson G.

Pediatr Radiol. 2001 Dec;31(12):848-51. Review.

PMID:
11727018
42.

Limbic encephalitis and hyperactive foci on PET scan.

Fakhoury T, Abou-Khalil B, Kessler RM.

Seizure. 1999 Oct;8(7):427-31.

43.

Retrospective intermodality registration techniques for images of the head: surface-based versus volume-based.

West J, Fitzpatrick JM, Wang MY, Dawant BM, Maurer CR Jr, Kessler RM, Maciunas RJ.

IEEE Trans Med Imaging. 1999 Feb;18(2):144-50.

PMID:
10232671
44.

Angiotensin II and coronary sympathetic vasodilation.

Kessler KM, Kessler RM.

Circulation. 1998 May 12;97(18):1873-4. No abstract available.

PMID:
9603547
45.

Comparison and evaluation of retrospective intermodality brain image registration techniques.

West J, Fitzpatrick JM, Wang MY, Dawant BM, Maurer CR Jr, Kessler RM, Maciunas RJ, Barillot C, Lemoine D, Collignon A, Maes F, Suetens P, Vandermeulen D, van den Elsen PA, Napel S, Sumanaweera TS, Harkness B, Hemler PF, Hill DL, Hawkes DJ, Studholme C, Maintz JB, Viergever MA, Malandain G, Woods RP, et al.

J Comput Assist Tomogr. 1997 Jul-Aug;21(4):554-66.

PMID:
9216759
46.

Intrapleural fibrinolytics in management of empyema thoracis.

Temes RT, Follis F, Kessler RM, Pett SB Jr, Wernly JA.

Chest. 1996 Jul;110(1):102-6.

PMID:
8681611
47.

Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography.

Delbeke D, Lawrence SK, Abou-Khalil BW, Blumenkopf B, Kessler RM.

Invest Radiol. 1996 May;31(5):261-6.

PMID:
8724123
48.

Case report. MR and CT appearance of cardiac hemangioma.

Kemp JL, Kessler RM, Raizada V, Williamson MR.

J Comput Assist Tomogr. 1996 May-Jun;20(3):482-3.

PMID:
8626917
49.

Accurate localization of cortical convolutions in MR brain images.

Ge Y, Fitzpatrick JM, Dawant BM, Bao J, Kessler RM, Margolin RA.

IEEE Trans Med Imaging. 1996;15(4):418-28.

PMID:
18215924
50.

Multiple polyposis and adenocarcinoma arising in Barrett's esophagus.

Wong RS, Temes RT, Follis FM, Kessler RM, Pett SB Jr, Wernly JA.

Ann Thorac Surg. 1996 Jan;61(1):216-8.

PMID:
8561560

Supplemental Content

Loading ...
Support Center